HPA1 activators, also known as High-Performance Activators 1, are a specific class of chemical compounds that primarily function to modulate cellular responses and signaling pathways within biological systems. These activators play a crucial role in regulating various cellular processes, often by targeting specific receptors or enzymes. While the exact structural characteristics of HPA1 activators may vary, they typically possess chemical properties that allow them to interact with specific molecular targets in cells. This interaction can lead to the activation or enhancement of certain cellular pathways, ultimately influencing a wide range of biological activities.
HPA1 activators are recognized for their ability to induce specific biochemical responses within cells, which can have profound effects on cellular behavior and function. These compounds may exert their effects through various mechanisms, such as binding to cell surface receptors, modifying enzyme activity, or modulating intracellular signaling cascades. The precise mode of action can vary depending on the specific HPA1 activator and its molecular target. Researchers often study these compounds to better understand cellular processes and pathways, as well as to explore applications in research and experimental settings. The characterization and manipulation of HPA1 activators contribute to our knowledge of cellular biology and provide valuable tools for investigating various aspects of cellular function and regulation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which can indirectly affect HPA1 activity by altering the glycosylation status of proteins that interact with or regulate HPA1. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Swainsonine is an inhibitor of Golgi alpha-mannosidase II. By altering glycosylation processes, it may indirectly impact HPA1 activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus, potentially influencing the trafficking and function of proteins that regulate HPA1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor. By preventing the degradation of certain proteins, it could indirectly affect the activity of HPA1 through altered protein-protein interactions. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, known for altering endosomal and lysosomal pH, can impact cellular trafficking, potentially affecting HPA1 activity indirectly. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By modulating tyrosine kinase activity, it may indirectly influence signaling pathways that regulate HPA1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known for its broad biological effects, including modulation of various signaling pathways that could indirectly affect HPA1 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. This could indirectly influence HPA1 activity through cAMP-dependent signaling pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. By modulating the Rho/ROCK pathway, it may have indirect effects on HPA1 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which could indirectly influence HPA1 activity. | ||||||